Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome

Inflammation Research

Volumn 60, Issue 2, 2011, Pages 137-142

  De Azevedo Lucio, Eraldo ^a,c   Gonçalves, Sandro C ^a   Ribeiro, Jorge P ^a,b   Nunes, Gilberto L ^a,c   De Oliveira, Jarbas R ^d   Araujo, Gustavo N ^b   Wainstein, Marco V ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c HOSPITAL SÃO FRANCISCO   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Atherosclerosis; Biomarkers; Inflammation

Indexed keywords

CREATINE KINASE MB; MYELOPEROXIDASE; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MALE; MYELOPEROXIDASE BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; RISK FACTORS;

EID: 79951724052     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0247-8     Document Type: Article

References (37)

1. P Libby PM Ridker A Maseri 2002 Inflammation and atherosclerosis Circulation 105 1135 1143 1:CAS:528:DC%2BD38XislWhu7k%3D 10.1161/hc0902.104353 11877368 (Pubitemid 34212626)
2. S de Servi A Mazzone G Ricevuti, et al. 1996 Expression of neutrophil and monocyte CD11B/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris Am J Cardiol 78 564 568 10.1016/S0002-9149(96)00367- 0 8806345 (Pubitemid 126658598)
3. A Buffon LM Biasucci G Liuzzo G D'Onofrio F Crea A Maseri 2002 Widespread coronary inflammation in unstable angina N Engl J Med 347 5 12 10.1056/NEJMoa012295 12097534 (Pubitemid 34728951)
4. T Naruko M Ueda K Haze, et al. 2002 Neutrophil infiltration of culprit lesions in acute coronary syndromes Circulation 106 2894 2900 10.1161/01.CIR.0000042674.89762.20 12460868 (Pubitemid 35424738)
5. SJ Nicholls SL Hazen 2005 Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 1102 1111 1:CAS:528:DC%2BD2MXksVWqsLk%3D 10.1161/01.ATV.0000163262.83456.6d 15790935 (Pubitemid 40776595)
6. SJ Klebanoff 2005 Myeloperoxidase: friend and foe J Leukoc Biol 77 598 625 1:CAS:528:DC%2BD2MXktFentLw%3D 10.1189/jlb.1204697 15689384 (Pubitemid 40628741)
7. EA Podrez HM Abu-Soud SL Hazen 2000 Myeloperoxidase-generated oxidants and atherosclerosis Free Radic Biol Med 28 1717 1725 1:CAS:528: DC%2BD3cXls1Giu7Y%3D 10.1016/S0891-5849(00)00229-X 10946213 (Pubitemid 30628658)
8. ML Brennan SL Hazen 2003 Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment Curr Opin Lipidol 14 353 359 1:CAS:528:DC%2BD3sXlsVKnsrc%3D 10.1097/00041433-200308000-00003 12865732 (Pubitemid 36951900)
9. SL Hazen 2004 Myeloperoxidase and plaque vulnerability Arterioscler Thromb Vasc Biol 24 1143 1146 1:CAS:528:DC%2BD2cXlsVygur8%3D 10.1161/01.ATV.0000135267.82813.52 15237089 (Pubitemid 38880000)
10. F Shabani J McNeil L Tippett 1998 The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCL) is suppressed by anti-rheumatic drugs Free Radical Res 28 115 123 1:CAS:528:DyaK1cXjvFemtbc%3D 10.3109/10715769809065797 (Pubitemid 28288697)
11. X Fu SY Kassim WC Parks JW Heinecke 2001 Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Bio Chem 276 41279 41287 1:STN:280:DC%2BD3Mnks12mtQ%3D%3D 10.1074/jbc.M106958200
12. ML Brennan MS Penn S Van Lente, et al. 2003 Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 1595 1604 1:CAS:528:DC%2BD3sXosFWktbo%3D 10.1056/NEJMoa035003 14573731 (Pubitemid 37288567)
13. S Baldus C Heeschen T Meinertz, et al. 2003 Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 1440 1445 1:CAS:528:DC%2BD3sXntlartb0%3D 10.1161/01.CIR.0000090690.67322.51 12952835 (Pubitemid 37176448)
14. E Cavusoglu C Ruwend C Eng, et al. 2007 Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome Am J Cardiol 99 1364 1368 1:CAS:528:DC%2BD2sXlt1eqtbg%3D 10.1016/j.amjcard.2006.12.060 17493461 (Pubitemid 46686633)
15. Morrow DA, Sabatine MS, Brennan ML, et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 2008;29:1096-12.
16. TJ Mocatta AP Pilbrow VA Cameron, et al. 2007 Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J Am Coll Cardiol 49 1993 2000 1:CAS:528:DC%2BD2sXlsF2hur4%3D 10.1016/j.jacc.2007.02.040 17512353 (Pubitemid 46734639)
17. SQ Khan D Kelly P Quinn JE Davies LL Ng 2007 Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction Heart 93 826 831 1:CAS:528:DC%2BD2sXot1KmsL8%3D 10.1136/hrt.2006.091041 17194712 (Pubitemid 46998982)
18. G Ndrepepa S Braun J Mehilli N von Beckerath A Schömig A Kastrati 2008 Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 90 96 1:CAS:528: DC%2BD1cXjsVeqsLw%3D 10.1111/j.1365-2362.2007.01908.x 18226042 (Pubitemid 351143413)
19. FK Borges FK Borges FS Stella, et al. 2009 Serial analysis of C-reactive protein and myeloperoxidase in acute coronary syndrome Clin Cardiol 32 E58 62 10.1002/clc.20462 19816870
20. R Zhang ML Brennan X Fu, et al. 2001 Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2136 2142 1:CAS:528:DC%2BD3MXot1Wqu78%3D 10.1001/jama.286.17.2136 11694155 (Pubitemid 34041599)
21. S Sugiyama Y Okada GK Sukhova R Virmani JW Heinecke P Libby 2001 Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am J Pathol 158 879 891 1:CAS:528:DC%2BD3MXitlOnurY%3D 11238037 (Pubitemid 32221781)
22. FR Tavora M Ripple L Li AP Burke 2009 Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques BMC Cardiovasc Disord 9 27 10.1186/1471-2261-9-27 19549340
23. RV Wainstein MV Wainstein JP Wainstein, et al. 2010 Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease Clin Biochem 43 57 62 1:CAS:528:DC%2BC3cXosleq 10.1016/j.clinbiochem.2009.07.022 19651119
24. EM Antman M Cohen PJLM Bernink, et al. 2000 The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 835 842 1:STN:280:DC%2BD3cvhsVagtA%3D%3D 10.1001/jama.284.7.835 10938172 (Pubitemid 30643610)
25. GG Gensini 1983 A more meaningful scoring system for determining the severity of coronary heart disease Am J Cardiol 51 606 1:STN:280: DyaL3s7itlyitw%3D%3D 10.1016/S0002-9149(83)80105-2 6823874 (Pubitemid 13187192)
26. O Düzgünçinar B Yavuz T Hazirolan, et al. 2008 Plasma myeloperoxidase is related to the severity of coronary artery disease Acta Cardiol 63 147 152 10.2143/AC.63.2.2029520 18468192 (Pubitemid 351548698)
27. E Cavusoglu V Chopra A Gupta, et al. 2006 Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography Am J Cardiol 98 1189 1193 10.1016/j.amjcard. 2006.05.048 17056325 (Pubitemid 44584101)
28. L Kubala G Lu S Baldus L Berglund JP Eiserich 2008 Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease Clin Chim Acta 394 59 62 1:CAS:528:DC%2BD1cXmvFems7o%3D 10.1016/j.cca.2008.04. 001 18440308
29. TK Rudolph V Rudolph S Baldus 2008 Contribution of myeloperoxidase to smoking-dependent vascular inflammation Proc Am Thorac Soc 5 820 823 10.1513/pats.200807-063TH 19017736
30. BU Goldmann V Rudolph TK Rudolph, et al. 2009 Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction Free Radic Biol Med 47 79 83 1:CAS:528:DC%2BD1MXms1yhsbg%3D 10.1016/j.freeradbiomed. 2009.04.004 19362143
31. Fragmin and Fast Revascularization during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
32. CP Cannon WS Weintraub LA Demopoulas, et al. 2001 Comparison of early invasive and conservative strategies in patients with acute coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Eng J Med 344 1879 1887 1:CAS:528:DC%2BD3MXltFers70%3D 10.1056/NEJM200106213442501 (Pubitemid 32564900)
33. MV Wainstein D Bento da Silva JP Ribeiro 2008 Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes Int J Cardiol 130 503 504 10.1016/j.ijcard.2007.07.051 17919751
34. MV Wainstein JP Ribeiro 2009 Mechanical plaque sealing in patients with acute coronary syndromes Int J Cardiol 135 105 106 10.1016/j.ijcard.2008.05.004
35. MV Wainstein JP Ribeiro 2009 What seals inflammation in patients with acute coronary syndromes Int J Cardiol 135 108 10.1016/j.ijcard.2008.05.002
36. N Clausell KF Prado JP Ribeiro 1999 Increased plasma levels of soluble vascular cellular adhesion molecule 1 in patients with chest pain and angiographically normal coronary arteries Int J Cardiol 68 275 280 1:STN:280:DyaK1M3ivVaqsA%3D%3D 10.1016/S0167-5273(98)00370-2 10213278 (Pubitemid 29138937)
37. SR Metha CB Granger WE Boden, et al. 2009 Early versus delayed invasive intervention in acute coronary syndromes N Eng J Med 360 2165 2175 10.1056/NEJMoa0807986